Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fiammetta Di Nardo
Institution:
University of Campania "Luigi Vanvitelli"
Observed institution:
University of Campania "Luigi Vanvitelli"
ORCID:
0009-0000-0519-3049
Observed ORCID:
0009-0000-0519-3049
OpenAlex ID:
A5060253537
From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
2025
·
Mario Romeo
, Alessia Silvestrin
, et al.
·
Biomedicines
·
32
PDF
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?
2025
·
Mario Romeo
, Marcello Dallio
, et al.
·
Diagnostics
·
31
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications
2025
·
Mario Romeo
, Marcello Dallio
, et al.
·
Journal of Personalized Medicine
·
15
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
2025
·
Marcello Dallio
, Mario Romeo
, et al.
·
International Journal of Molecular Sciences
·
10
PDF
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the “Bermuda” triangle of malnutrition-sarcopenia-frailty severely affecting prognosis
2025
·
Marcello Dallio
, Mario Romeo
, et al.
·
Nutrition Journal
·
10
PDF
Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis
2025
·
Marcello Dallio
, Mario Romeo
, et al.
·
Journal of Clinical and Experimental Hepatology
·
8
PDF
Beneficial Effects of Long-Lasting Bicarbonate–Sulfate–Calcium–Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcomes via Impacting Intestinal Permeability (IP), IP-Related Systemic Inflammation, and Oxidative Stress
2025
·
Marcello Dallio
, Mario Romeo
, et al.
·
Nutrients
·
6
PDF
From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life
2025
·
Marcello Dallio
, Mario Romeo
, et al.
·
Livers
·
5
PDF
Exploring the Classic and Novel Pathogenetic Insights of Plastic Exposure in the Genesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
2025
·
Mario Romeo
, Marcello Dallio
, et al.
·
Livers
·
4
PDF
Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece?
2024
·
Marcello Dallio
, Mario Romeo
, et al.
·
Livers
·
4
The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives
2025
·
Mario Romeo
, Fiammetta Di Nardo
, et al.
·
Journal of Personalized Medicine
·
3
PDF
Phase Angle/C-reactive Protein-Index as a Novel Combined Tool for Predicting Liver-Related Hospitalizations in MASLD-Decompensated Cirrhosis
2025
·
Marcello Dallio
, Mario Romeo
, et al.
·
Archives of Medical Research
·
3
Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review
2025
·
Mario Romeo
, Fiammetta Di Nardo
, et al.
·
Diabetology
·
3
PDF
Risk stratification of non-acute decompensation in alcohol-related cirrhosis using the red cell distribution width-to-platelet ratio
2026
·
Mario Romeo
, Viktor Domislović
, et al.
·
Digestive and Liver Disease
·
2
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Chronic Liver Diseases: Translating Mechanistic Insights into Clinical Practice and Future Perspectives
2026
·
Mario Romeo
, Claudio Basile
, et al.
·
Cells
·
2
PDF
Redefining Liver Transplantation Indications for Hepatic Malignancies in the Era of Precision Transplant Oncology: An Up-to-Date Narrative Review
2026
·
Mario Romeo
, Fiammetta Di Nardo
, et al.
·
Journal of Clinical Medicine
·
2
PDF
Human Albumin-enriched Peritoneal Dialysis: A Novel Approach to Manage Refractory Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease
2025
·
Mario Romeo
, Silvio Borrelli
, et al.
·
Journal of Clinical and Translational Hepatology
·
2
PDF
Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap?
2024
·
Mario Romeo
, Fiammetta Di Nardo
, et al.
·
Digestive and Liver Disease
·
2
Metabolic dysfunction profiles identify heterogeneous hepatocellular carcinoma risk in MASLD-associated advanced fibrosis
2026
·
Mario Romeo
, Marcello Dallio
, et al.
·
Journal of Hepatology
·
1
PDF
THU-186-YI Distinct cardiometabolic profiles drive divergent HCC risk trajectories in advanced fibrosis-affected MASLD patients
2026
·
Mario Romeo
, Marcello Dallio
, et al.
·
Journal of Hepatology
·
1
Beyond Insulin Resistance: Exploring the Centrality of the Gut–Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and Diabetes
2026
·
Mario Romeo
, Claudio Basile
, et al.
·
Cancers
·
1
PDF
Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach
2025
·
Mario Romeo
, Carmine Napolitano
, et al.
·
Livers
·
1
PDF
Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot?
2025
·
Mario Romeo
, Fiammetta Di Nardo
, et al.
·
Alimentary Pharmacology & Therapeutics
·
1
PDF
Effectiveness and safety of three years of bulevirtide monotherapy in patients with HDV-related compensated cirrhosis: the Italian compassionate use program
2026
·
Maria Paola Anolli
, Elisabetta Degasperi
, et al.
·
Digestive and Liver Disease
PDF
A multidisciplinary nutritional-behavioral intervention improves weight loss and liver-related outcomes in patients with metabolic dysfunction-associated steatotic liver disease: A randomized controlled trial
2026
·
Marcello Dallio
, Mario Romeo
, et al.
·
Clinical Nutrition
Show more works
View as search
Works count:
49
Citation count:
149
H-index:
6
I10-index:
5
Year
Topic
Type